BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu TH, Wang YC, Cheng CH, Lee CF, Wu TJ, Chou HS, Chan KM, Lee WC. Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma. World J Gastrointest Surg 2020; 12(1): 17-27 [PMID: 31984121 DOI: 10.4240/wjgs.v12.i1.17]
URL: https://www.wjgnet.com/1948-5182/full/v12/i1/17.htm
Number Citing Articles
1
Kohei Ogawa, Yasutsugu Takada. Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver TransplantationCancers 2022; 14(2): 396 doi: 10.3390/cancers14020396
2
Wei-Cheng Wang, Tsung-Han Wu, Hao-Chien Hung, Jin-Chiao Lee, Chih-Hsien Cheng, Yu-Chao Wang, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan, Wei-Chen Lee. Liver regeneration of living donor after liver donation for transplantation: Disparity in the left and right remnant liverMedicine 2024; 103(14): e37632 doi: 10.1097/MD.0000000000037632
3
Tommy Ivanics, Marco P.A.W. Claasen, Benjamin Samstein, Jean C. Emond, Alyson N. Fox, Elizabeth Pomfret, James Pomposelli, Parissa Tabrizian, Sander S. Florman, Neil Mehta, John P. Roberts, Juliet A. Emamaullee, Yuri Genyk, Roberto Hernandez-Alejandro, Koji Tomiyama, Kazunari Sasaki, Koji Hashimoto, Shunji Nagai, Marwan Abouljoud, Kim M. Olthoff, Maarouf A. Hoteit, Julie Heimbach, Timucin Taner, AnnMarie H. Liapakis, David C. Mulligan, Gonzalo Sapisochin, Karim J. Halazun. Living Donor Liver Transplantation for Hepatocellular Carcinoma Within and Outside Traditional Selection CriteriaAnnals of Surgery 2024; 279(1): 104 doi: 10.1097/SLA.0000000000006049
4
Yi-Fan Tsou, Niang-Cheng Lin, Cheng-Yuan Hsia, Che-Chuan Loong, Hsin-Lin Tsai, Cheng-Yen Chen, Hao-Jan Lei, Shu-Cheng Chou, Meng-Hsuan Chung, Fang-Cheng Kuo, Chin-Su Liu. Repeated loco-regional therapies for hepatocellular carcinoma is associated with inferior outcome after living donor liver transplantation in cirrhotic patientsJournal of the Chinese Medical Association 2022; 85(3): 317 doi: 10.1097/JCMA.0000000000000670
5
Toshiaki Nakano, Chao-Long Chen, I-Hsuan Chen, Hui-Peng Tseng, Kuei-Chen Chiang, Chia-Yun Lai, Li-Wen Hsu, Shigeru Goto, Chih-Che Lin, Yu-Fan Cheng. Overexpression of miR-4669 Enhances Tumor Aggressiveness and Generates an Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma: Its Clinical Value as a Predictive BiomarkerInternational Journal of Molecular Sciences 2023; 24(9): 7908 doi: 10.3390/ijms24097908